The LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer.

Yangming ChenYujie LeiJianbin LinYunchao HuangJiguang ZhangKai ChenShihui SunXing Lin

Published in: OncoTargets and therapy (2020)

This study revealed a novel LINC01260/miR-562/CYLD/NF-κB pathway in the pathogenesis of NSCLC and suggested a potential therapeutic target for NSCLC.

Keyphrases